PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Analgesic effects of the novel alpha2delta ligand mirogabalin in a rat model of spinal cord injury.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30396385 ↗2018Reported benefit

Analgesic effects of the novel alpha2delta ligand mirogabalin in a rat model of spinal cord injury.

RatSpinal cord injuryCompressionSprague-DawleyMaleOral2.5, 5 or 10 mg/kg28 days after spinal cord injury

Model: Acute compression of the spinal cord at the T6/7 level with a microvascular clip; testing 28 days after injury

A single oral dose of mirogabalin significantly raised the paw withdrawal threshold and the paw withdrawal threshold area under the curve relative to control, with effects still significant at 6 to 8 h after administration.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.